Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Scientists Engineer Human Stem Cells and Move Closer to Mastering Regenerative Medicine

Published: Wednesday, December 11, 2013
Last Updated: Wednesday, December 11, 2013
Bookmark and Share
Researchers have successfully converted human embryonic stem cells (hESCs) cultured in the laboratory to a state that is closer to the cells found in the human blastocyst.

This means that scientists are one step closer to cultivating stem cells for research and potential therapeutic purposes, as well as understanding the processes of early human development. These findings are published in the current issue of the prestigious science journal Cell Stem Cell.

Pluripotent stem cells such as hESCs and induced pluripotent stem cells (iPSCs) have the remarkable ability to differentiate into various cell types of the adult body while proliferating continuously in culture. In the field of regenerative medicine, these cells are potentially a limitless resource to generate cells of different body parts such as the eye, liver, brain, kidney and pancreas to treat degenerative diseases or replace of worn out organs. Pluripotency is the essential property of the cells of the blastocyst in the early stages of human development. However, when cultured in the laboratory, these cells adopt molecular differences, which limit their use in therapeutic applications or disease modeling.

Using previously established hESCs, the researchers screened for culture conditions that could induce a stable change of cell state. They found that the use of a specific combination of small molecules and growth factors, termed 3iL, converted hESCs to a state that resembled cells within the native blastocysts.

The GIS team’s discovery will empower researchers with a novel resource to tackle existing challenges. “For the past 15 years, scientists could only work on a single hESC state. We now provide a novel cell state for all hESC applications,” said Prof Ng Huck Hui. “The results from the study will open many new possibilities to study human development and disease. The 3iL hESCs will help to overcome some of the obstacles that limit the potential of pluripotent cells in regenerative medicine.”

The researchers also found that many genes which are active in blastocyst cells but inactive in hESCs were turned on again in this novel cell state. These re-activated genes also showed epigenetic differences. “Every cell has a ’memory’, the epigenome, which is a layer on top of the genome that marks active and inactive genes,” explained Dr Jonathan Göke, a bioinformatician from GIS “When we looked into the epigenome of these 3iL cells, we found that this ‘memory’ was dramatically different; the cells appeared to be partly set back to the state of the embryo.”

To demonstrate how these 3iL hESCs can be used to obtain insights into human development, Prof Ng’s team studied the regulatory system that controls these developmental genes. “Studies of basic mechanisms like gene regulation require a large number of cells,” said Dr Chan Yun Shen, co-lead author, and researcher at GIS. “This is the first time that we are able to see how these genes are potentially regulated. While additional experiments will help to fully characterize these 3iL hESCs, we can already see that they provide an unprecedented way to study early human development without the use of any blastocysts.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Singapore Scientists’ made Significant Discovery for Stem Cell Technology and Clinical Research
Scientists reveal important insights into how researchers can manipulate and engineer different stem cells for the treatment of human degenerative disorders.
Tuesday, September 23, 2008
Scientists Found a Way to Enhance Development of Human Embryonic Stem Cells Therapies
Scientists at the Genome Institute of Singapore and the National University of Singapore have found a way of manipulating ESCs that allows stem cells to be produced for use in clinical treatments.
Tuesday, January 23, 2007
Scientific News
Nanosensors Could Determine Tumours’ Ability to Remodel Tissue
Researchers design nanosensors that can profile tumours, focusing on protease levels.
1960s Antibiotics Show Promise for TB Therapy
Research suggests antibiotics introduced in 1963 to treat bacterial infections show promise for tuberculosis therapy.
Insight into Eye Diseases
Scientists recreate zebrafish cell regeneration from retinal stem cells in mice.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Studies Explore the Science of Cardiovascular Diseases
Two studies highlight how basic science research insights are key to future treatment breakthroughs.
Stem Cell ‘Heart Patch’ Almost Perfected
Scientists aiming to perfect and test 3D "heart patches" in animal model, last hurdle before human patients.
Using Stem Cells to Grow a 3D Lung-in-a-Dish
Researchers have created 3D lung-like tissue from lung-derived stem cells. The tissue can be used to study lung diseases.
MRI Guidance Aids Stem Cell Delivery
Scientists have delivered stem cells to the brain with unprecedented precision, infusing the cells under real-time MRI guidance.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!